Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Medical Condition: Health Condition 1: E119- Type 2 diabetes mellitus without complications"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Health+Condition+1%3A+E119-+Type+2+diabetes+mellitus+without+complications%22&lookfor=%22Diabetes+Mellitus%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Health+Condition+1%3A+E119-+Type+2+diabetes+mellitus+without+complications%22&lookfor=%22Diabetes+Mellitus%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Health+Condition+1%3A+E119-+Type+2+diabetes+mellitus+without+complications%22&lookfor=%22Diabetes+Mellitus%22&type=Subject
PubPharm (1.006)
1
Clinical trial of Amruta Guggulu in the management of Diabetes : An open labeled Randomized controlled trial of Amruta Guggulu as an add-oneffect in the management of Madhumeha.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A multinational,randomized open-label,parallel-group, active-controlled,two-arm, long-term morbidity and mortality trial involving intensive preventive therapy (high dose renin-angiotensin-aldosterone system inhibitors [RAASi],beta-blockade,sodium-glucoseco-transporter 2 : A multinational, randomized open-label, parallel group, active-controlled, two-arm, long-termmorbidity and mortality trial involving intensive preventive therapy (high doserenin-angiotensin-aldosterone system inhibitors [RAASi], beta-blockade, sodium-glucoseco-transporter 2 inhibitors [SGLT2i]) among biomarker (N-terminal pro-B-type natriuretic peptide,NT-proBNP)-identified high risk type 2 DM patients without pre-existing cardiovascular disease - ADOPT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to assess the relationship between blood glucose control and self-management activities including diet, exercise, sleep, medication consumption and other daily routines for individuals with type 2 diabetes. : PROSPECTIVE COHORT STUDY OF FACTORS INFLUENCING GLUCOSE CONTROL AMONG INDIANS WITH TYPE 2 DIABETES
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
An observational study to understand effectiveness, initiation (starting) and patient satisfaction of Insulin Glargine among type 2 Diabetes Mellitus patients in primary care settings in India : An observational study in PRIMARY Care settings in India to assess clinical outcomes, initiation patterns, and treatment-satisfaction in type 2 Diabetes Mellitus patients initiated on Insulin glargine (PRIMARY-India study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Patients with Type 2 Diabetes Mellitus by using Glycemic Happiness : A prospective, Multicentric, cross-sectional study to evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Diabetes is considered to be a chronic disease requiring prolonged medication. Recent evidences shows that Diabetes can be reversed or in other words can be controlled to that extent when there might not be any requirement for medicine. We will try to achieve that among our patients. : A randomized control trial to study the reversibility of Type 2 Diabetes Mellitus using combination drug therapy of Semaglutide and Dapagliflozine as an add on to Metformin monotherapy in comparison to standard clinical management and to find the reversibility of alterations in proteomics and immune inflammatory markers after remission of diabetes
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A clinical study to assess the efficacy and safety of combination of Dapagliflozin plus Linagliptin Tablets in patients with diabetes. : â??A Phase III, Prospective, Randomized, Double Blind, Double Dummy, Active-Controlled, Comparative, Parallel Group, Multicentric Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Dose Combination of Dapagliflozin plus Linagliptin Tablets in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy.â??
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A clinical study to evaluate the efficacy and safety of NATBERB as a add on therapy for Type 2 diabetes Mellitus : An Open-labelled, Single Arm, Interventional Clinical Study to Evaluate the Efficacy and Safety of NATBERB (100% Natural Berberine) as an adjuvant therapy in Type 2 Diabetes mellitus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Effect of Sitagliptin, Glimepiride and Extended Release Metformin Hydrochloride Tablets in Comparison to Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets in Patients with Diabetes : A Multicenter, Randomized, Comparative, Active-Controlled, Open-Label, Phase 3 Study to Assess Efficacy and Safety of Sitagliptin, Glimepiride and Extended Release Metformin Hydrochloride Tablets in Comparison to Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets in Patients with Type 2 Diabetes Mellitus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Effectiveness of Low carb products in mitigating blood sugar spikes in patients with Type 2 Diabetes Mellitus. : A pilot study to evaluate the efficacy and safety of low carb DiabeSmart Atta Additive DiabeSmart South Indian Mixture and DiabeSmart Ultra-low carb atta in lowering hyperglycemia in comparison with standard carbohydrate diet among diabetics and pre diabetics.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[101]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Medical Condition: Health Condition 1: E119- Type 2 diabetes mellitus without complications
Medienart
1.006
Aufsätze
1.006
E-Artikel
1.006
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.006
610
Medical Condition: Health Condition 1: E119- Ty...
812
Study Type: Interventional
588
Recruitment Status: Not yet recruiting
232
Recruitment Status: Completed
172
Study Type: Observational
150
Phase: Phase 3
140
Phase: Phase 2
108
Recruitment Status: Recruiting
80
Phase: Phase 4
72
Phase: Phase 2/Phase 3
62
Recruitment Status: Closed to Recruitment of Pa...
30
Phase: Post Marketing Surveillance
28
Phase: Phase 1
24
Phase: Phase 1/Phase 2
22
Study Type: PMS
18
Phase: Phase 3/Phase 4
8
Recruitment Status: Terminated
4
Recruitment Status: Suspended
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
224
2023
310
2022
472
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
994
Englisch
12
Unbestimmt
Haven't found what you're looking for?
Wird geladen...